PYXS News and Press, Pyxis Oncology Inc. From 11/10/21

CAMBRIDGE, Mass., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), today announced that management will present at and host one-on-one investor meetings during the virtual portion of the Jefferies London Healthcare Conference, taking place November 18-19, 2021. Th...

Jefferies has initiated Pyxis Oncology (NASDAQ:PYXS) with a buy rating due to the company's development of next-generation antibody drug conjugates ("AJC") for cancer indications. The firm has a price target of $25 (~89% return). Analyst Eun Yang writes that the company has three AJCs poised ...

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...